Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Yale University logo

Yale University

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: Buprenorphine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000319
NIDA-09803-2
R01DA009803 (U.S. NIH Grant/Contract)
R01-09803-2

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.

Sex

All

Ages

21 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems